SPONSOR
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Total Trials
6
Recruiting
6
Phases
Phase 3, Phase 2
Conditions studied: DepressionDepressive DisorderDown SyndromeDown Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer DementiaAlzheimer Dementia (AD)Alzheimer DiseaseAlzheimer Disease (AD)Alzheimer Blood Biomarkers
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Depression, Depressive Disorder, Down Syndrome, Down Syndrome (DS).
The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
How many clinical trials has Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, of which 6 are actively recruiting participants. These trials cover conditions including Depression, Depressive Disorder, Down Syndrome. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau research focus on?
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau clinical trials span Depression, Depressive Disorder, Down Syndrome, Down Syndrome (DS), Down Syndrome (Trisomy 21), and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau clinical trial?
To participate in a Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials with current recruitment status updated daily.
Clinical Trials by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
NCT06590025 Phase 3
Recruiting
Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression
Depression
NCT07234695 Phase 3
Recruiting
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Down Syndrome
NCT07551882 Phase 2
Recruiting
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
Self-compassion Training (SCT) Plus Intranasal Oxytocin
NCT07098975 Phase 2
Recruiting
Statin Intervention for Severe Early-Onset Placental Insufficiency. (STATIN-PRE Trial)
Preeclampsia (PE)
NCT04236492
Recruiting
Study Protocol to Evaluate Clinical and Imaging Results of Knee Fresh Osteochondral Allografts
Osteochondral Defect
NCT07188220
Recruiting
Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study
Metabolic Dysfunction Associated Steatohepatitis (MASH)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology